Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11224-020-01605-w http://scihub22266oqcxt.onion/10.1007/s11224-020-01605-w 32837119!7418093!32837119     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Struct+Chem 2020 ; 31 (6): 2487-2499 Nephropedia Template TP {{tp|p=32837119|t=2020. Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19 |pdf=|usr=}}{{32837119}} gab.com Text Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19 JO: Struct Chem http://www.kidney.de/pget.php?&tw=1&pmid=32837119 #FOAvip The outbreak of severe acute respiratory syndrome coronavirus-2 is causing a serious disaster through coronavirus disease-19 (COVID-19) around the globe. A large segment of the population from every corner of the world is already infected with this dreadful pathogen with a high mortality rate. These numbers are increasing drastically causing a situation of a global pandemic. Although after the continuous scientific efforts, we are still not having any specific drug or vaccine for the SARS-CoV-2 pathogen to date and there is an urgent need to develop a newer therapy to counter the COVID-19 global pandemic. Thus, in the current study, a framework for computational drug repurposing is established, and based on their safety profile, metocurine was chosen as a safe and effective drug candidate for developing therapy against the viral Mpro enzyme of SARS-CoV-2 for the treatment of COVID-19. Twit Text FOAVip Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19 ????Struct Chem http://www.kidney.de/pget.php?&tw=1&pmid=32837119 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32837119 #FOAvip English Wikipedia <ref>{{Cite pmid|32837119}}</ref> Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19 #MMPMID32837119 Jain R; Mujwar S Struct Chem 2020[]; 31 (6): 2487-2499 PMID32837119show ga The outbreak of severe acute respiratory syndrome coronavirus-2 is causing a serious disaster through coronavirus disease-19 (COVID-19) around the globe. A large segment of the population from every corner of the world is already infected with this dreadful pathogen with a high mortality rate. These numbers are increasing drastically causing a situation of a global pandemic. Although after the continuous scientific efforts, we are still not having any specific drug or vaccine for the SARS-CoV-2 pathogen to date and there is an urgent need to develop a newer therapy to counter the COVID-19 global pandemic. Thus, in the current study, a framework for computational drug repurposing is established, and based on their safety profile, metocurine was chosen as a safe and effective drug candidate for developing therapy against the viral Mpro enzyme of SARS-CoV-2 for the treatment of COVID-19. äRepurposing metocurine as main protease inhibitor to develop novel ant(epmc).pdf DeepDyve Pubget Overpricing